AZN vs NPCE · P/E 28, $288.38B cap vs rev $22.8M
AstraZeneca PLC (AZN) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the AZN and NPCE stock pages for the full models.
Not investment advice.